{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:23:36Z","timestamp":1790436216229,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ygyno.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T18:28:41Z","timestamp":1626114521000},"page":"804-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"162","author":[{"given":"Antonio","family":"Travaglino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Raffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Arciuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"D'alessandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Casadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frediano","family":"Inzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Seracchioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.07.007_bb0005","series-title":"Female Genital Tumours. Lyon (France): International Agency for Research on Cancer","volume":"vol. 4","author":"WHO Classification of Tumours Editorial Board","year":"2020"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.07.007_bb0010","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"10.1016\/j.ygyno.2021.07.007_bb0015","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/PAS.0000000000001519","article-title":"Molecular profiles of mixed endometrial carcinoma","volume":"44","author":"Matrai","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.007_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/his.12286","article-title":"Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1\u03b2 and oestrogen receptor","volume":"64","author":"Hoang","year":"2014","journal-title":"Histopathology."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.007_bb0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PGP.0000000000000609","article-title":"Use of Immunohistochemical markers (HNF-1\u03b2, Napsin a, ER, CTH, and ASS1) to distinguish endometrial clear cell carcinoma from its morphologic mimics including arias-Stella reaction","volume":"39","author":"Ji","year":"2020","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"8","key":"10.1016\/j.ygyno.2021.07.007_bb0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PAI.0000000000000801","article-title":"Napsin-a and AMACR are superior to HNF-1\u03b2 in distinguishing between mesonephric carcinomas and clear cell carcinomas of the gynecologic tract","volume":"28","author":"Pors","year":"2020","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.007_bb0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/PGP.0000000000000430","article-title":"Morphologic and Immunohistochemical study of clear cell carcinoma of the uterine endometrium and cervix in comparison to ovarian clear cell carcinoma","volume":"37","author":"Ju","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.007_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","article-title":"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification","volume":"444","author":"Lax","year":"2004","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.007_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.5511","article-title":"Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours","volume":"252","author":"Cochrane","year":"2020","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.07.007_bb0050","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/01.pas.0000213296.88778.db","article-title":"Precursors of endometrial clear cell carcinoma","volume":"30","author":"Fadare","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.007_bb0055","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/his.12581","article-title":"Targeted mutation analysis of endometrial clear cell carcinoma","volume":"66","author":"Hoang","year":"2015","journal-title":"Histopathology."},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.007_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PGP.0000000000000111","article-title":"Should endometrial clear cell carcinoma be classified as type II endometrial carcinoma?","volume":"34","author":"Bae","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"7447","key":"10.1016\/j.ygyno.2021.07.007_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.007_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.007_bb0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.007_bb0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.007_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2019.03.098","article-title":"Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma","volume":"153","author":"Britton","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.ygyno.2021.07.007_bb0090","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and Clinicopathological factors in early-stage endometrial Cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.007_bb0095","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA molecular groups of endometrial cancer: pooled data about prognosis","volume":"155","author":"Raffone","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.07.007_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-021-06028-4","article-title":"Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer","author":"Raffone","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.007_bb0105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ygyno.2020.01.008","article-title":"Histopathological characterization of ProMisE molecular groups of endometrial cancer","volume":"157","author":"Raffone","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.007_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.007_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ygyno.2021.02.029","article-title":"Clinico-pathological significance of TCGA classification and SWI\/SNF proteins expression in undifferentiated\/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification","volume":"161","author":"Santoro","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.007_bb0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/his.13976","article-title":"Clear cell endometrial carcinoma and the TCGA classification","volume":"76","author":"Travaglino","year":"2020","journal-title":"Histopathology."},{"key":"10.1016\/j.ygyno.2021.07.007_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev."},{"issue":"8","key":"10.1016\/j.ygyno.2021.07.007_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.007_bb0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.007_bb0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/PAS.0000000000000536","article-title":"Molecular analysis of mixed endometrial carcinomas shows Clonality in Most cases","volume":"40","author":"K\u00f6bel","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.007_bb0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.07.007_bb0150","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/PAS.0000000000001581","article-title":"BRG1, INI1, and ARID1B deficiency in endometrial carcinoma: a Clinicopathologic and Immunohistochemical analysis of a large series from a single institution","volume":"44","author":"Kihara","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.007_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2020.04.043","article-title":"Molecular subtypes of clear cell carcinoma of the endometrium: opportunities for prognostic and predictive stratification","volume":"158","author":"Kim","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.07.007_bb0160","doi-asserted-by":"crossref","first-page":"153383","DOI":"10.1016\/j.prp.2021.153383","article-title":"DNA mismatch repair deficiency and p53 abnormality are age-related events in mixed endometrial carcinoma with a clear cell component","volume":"220","author":"Ida","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"8","key":"10.1016\/j.ygyno.2021.07.007_bb0165","doi-asserted-by":"crossref","first-page":"153025","DOI":"10.1016\/j.prp.2020.153025","article-title":"Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer","volume":"216","author":"Raffone","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.007_bb0170","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s12253-020-00811-5","article-title":"Diagnostic accuracy of immunohistochemistry for mismatch repair proteins as surrogate of microsatellite instability molecular testing in endometrial Cancer","volume":"26","author":"Raffone","year":"2020","journal-title":"Pathol Oncol Res."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.007_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","article-title":"Molecular classification of grade 3 Endometrioid endometrial cancers identifies distinct prognostic subgroups","volume":"42","author":"Bosse","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.007_bb0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PAS.0000000000001598","article-title":"Molecularly classified uterine FIGO grade 3 Endometrioid carcinomas show distinctive clinical outcomes but overlapping morphologic features","volume":"45","author":"Joehlin-Price","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.007_bb0185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cjp2.18","article-title":"In-depth molecular profiling of the biphasic components of uterine carcinosarcomas","volume":"1","author":"McConechy","year":"2015","journal-title":"J Pathol Clin Res."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.007_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine Carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2021.07.007_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2019.06.005","article-title":"Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases","volume":"92","author":"Zannoni","year":"2019","journal-title":"Hum. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.007_bb0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PGP.0000000000000369","article-title":"Frequent mismatch repair protein deficiency in mixed Endometrioid and clear cell carcinoma of the endometrium","volume":"36","author":"K\u00f6bel","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.007_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0000000000001461","article-title":"Endometrial carcinomas with a \u201cserous\u201d component in Young women are enriched for DNA mismatch repair deficiency, lynch syndrome, and POLE exonuclease domain mutations","volume":"44","author":"Conlon","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2021.07.007_bb0210","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/PAS.0000000000001561","article-title":"DNA mismatch repair-deficient endometrial Carcinosarcomas portend distinct clinical, morphologic, and molecular features compared with traditional Carcinosarcomas","volume":"44","author":"Segura","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.007_bb0215","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/MMBR.00011-08","article-title":"Comparative genomics and molecular dynamics of DNA repeats in eukaryotes","volume":"72","author":"Richard","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"issue":"10","key":"10.1016\/j.ygyno.2021.07.007_bb0220","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2290::AID-CNCR13>3.0.CO;2-I","article-title":"Frameshift mutations at coding mononucleotide repeat microsatellites in endometrial carcinoma with microsatellite instability","volume":"88","author":"Catasus","year":"2000","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2021.07.007_bb0225","doi-asserted-by":"crossref","unstructured":"Gulcher J .Microsatellite markers for linkage and association studies. Cold Spring Harb Protoc 2012; 4:425\u2013432.","DOI":"10.1101\/pdb.top068510"},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.007_bb0230","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ygyno.2019.03.100","article-title":"Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers","volume":"153","author":"Moroney","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.007_bb0235","first-page":"425","article-title":"Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study","volume":"2012","author":"Raffone","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:59:43Z","timestamp":1758772783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821005370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0090825821005370"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.07.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}